facebook tracking

CDSCO

Central Government Prohibits Manufacture, Sale, and Distribution of 16 Irrational Fixed Dose Combinations


regulatory illustration
Regulatory update
Importer & Manufacturer   |   Source: CDSCO
Published On: 21-07-2026

Enforcement Date: 11 June, 2026
Central Government Prohibits Manufacture, Sale, and Distribution of 16 Irrational Fixed Dose Combinations

The Ministry of Health & Family Welfare has prohibited 16 Fixed Dose Combinations (FDCs) for human use under Section 26A of the Drugs and Cosmetics Act, 1940. Based on Expert Committee and DTAB recommendations, these combinations were found irrational, lacking therapeutic justification, and potentially risky to patients despite the availability of safer alternatives.


Through Gazette Notifications S.O. 3068(E) to S.O. 3083(E) dated 11 June 2026, the Central Government prohibited the manufacture, sale, and distribution of 16 Fixed Dose Combinations (FDCs) intended for human use. The banned FDCs include: Acetyl Salicylic Acid + Ethoheptazine; Aloe Vera + Jojoba Oil + Wheat Germ Oil + Tea Tree Oil; Amoxicillin + Serratiopeptidase + Lactobacillus Sporogenes; Dicyclomine + Paracetamol + Clidinium Bromide + Chlordiazepoxide; Amoxicillin + Serratiopeptidase; Aloe Extract + Allantoin + Alphatocopherol Acetate + D Panthenol + Vitamin A; Aloe Extract + Vitamin E + Dimethicone + Glycerine; Aloe Vera + Jojoba Oil + Vitamin E; Aloe Vera + Orange Oil; Aloe Vera + Vitamin E + Herbal; Dicyclomine + Paracetamol + Clidinium Bromide; Paracetamol + Lignocaine; Gliclazide + Chromium Picolinate; Amoxicillin + Cloxacillin + Lactic Acid Bacillus + Serratiopeptidase; Cefadroxyl + Probenecid; and Cefuroxime + Serratiopeptidase. The decision was taken under Section 26A of the Drugs and Cosmetics Act, 1940, following reviews by the Expert Committee, DTAB Sub-Committee, and Drugs Technical Advisory Board, which concluded that these FDCs lacked therapeutic justification, were unsupported by adequate scientific evidence, and posed potential risks to public health despite the availability of safer alternatives.

Applicable For: Importer & Manufacturer
Reference Number: CG-DL-E-19062026-273649 Notification Link

Related Regulatory Updates

Contact us

Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.